Tri-vylibra
Product Images NDC 53002-1776

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri-vylibra (NDC 53002-1776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021776)

Tri-VyLibra Tablets 28-Day pack label from RPK Pharmaceuticals, Inc. The label shows the dosage form as tablets, with instructions to take one tablet daily as directed. It includes NDC codes, lot number, expiration date, and placeholders for clinic name and patient information. The packaging is predominantly black and white with regulatory and usage information.*

FDA Label Image

Norgestimate-fig1.jpg (Norgestimate Fig1)

An instructional illustration for Tri-VyLibra tablets showing a hand peeling off a day label to place on the tablet packaging. The packaging contains four rows of tablets, color-coded as white, light blue, dark blue, and green. The diagram directs users to pick the correct day label and affix it, indicating the sequence of tablet intake by color and day.*

FDA Label Image

Norgestimate-fig2 (Norgestimate Fig2)

An instructional diagram showing the weekly pill regimen for Tri-VyLibra tablets. The image illustrates a 28-day cycle divided into four rows by color: white (starting circle), light blue, dark blue, and green, indicating the sequence of daily pills. Dosages for each dark blue tablet are labeled with amounts of norgestimate and ethinyl estradiol.*

FDA Label Image

Figure-3 (Norgestimate Fig3)

Diagram showing various birth control methods arranged vertically by effectiveness, with pregnancy rates ranging from fewer than 1 pregnancy per 100 women per year at the top to 85 or more pregnancies per 100 women per year at the bottom. Methods listed include implants, injections, intrauterine devices, sterilization at the top; birth control pills, skin patch, vaginal ring in the second tier; condoms and diaphragm in the middle; no sex during fertile days, spermicide, withdrawal below; and no birth control at the bottom associated with the highest pregnancy rates.*

FDA Label Image

Norgestimate-fig4 (Norgestimate Fig4)

An instructional illustration showing how to select and place the correct day label on a Tri-VyLibra oral tablet blister pack. The pack has four rows of 7 circular tablet pockets each, color-coded white, light blue, dark blue, and green, corresponding to different weeks of a dosage regimen. The image includes an annotated hand peeling and placing the day label at the top of the blister pack.*

FDA Label Image

Norgestimate-fig5 (Norgestimate Fig5)

An instructional diagram for taking Tri-VyLibra tablets that categorizes pills by color and weekly dosage schedule. The diagram shows white pills for week 1, light blue pills for week 2, dark blue pills for week 3, and green pills for week 4, arranged by day of the week starting Sunday. Each colored row corresponds to specific doses of norgestimate and ethinyl estradiol in a monthly cycle.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagram showing the molecular structures of Norgestimate and Ethinyl Estradiol, the active ingredients in Tri-VyLibra by RPK Pharmaceuticals, Inc. The diagram includes labeled atoms and bonds characteristic of these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.